Jan H. Schefe
Impact in
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
-
- Hormonal Regulation and Hypertension
Papers in
-
- Receptor Mechanisms and Signaling 5
- Protein purification and stability 1
- Peroxisome Proliferator-Activated Receptors 1
-
- Renin-Angiotensin System Studies 3
- Cardiac electrophysiology and arrhythmias 1
- Co-authors
- Thomas Unger (11 shared papers)Heiko Funke‐Kaiser (10 shared papers)Kerstin Lehmann (1 shared paper)Ivo Buschmann (1 shared paper)Mario Menk (4 shared papers)Jana Reinemund (4 shared papers)Robin M. Hobbs (1 shared paper)Karin Effertz (1 shared paper)
- Journals
- Journal of Hypertension (2 papers)Journal of Molecular Medicine (2 papers)Alcohol (1 paper)Biochemical Pharmacology (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- GermanyHungaryNetherlands
In The Last Decade
Jan H. Schefe
14 papers receiving 1.5k citations
Jan H. Schefe's Hit Papers
Peers
Comparison fields: 5 of 116
- Cardiology and Cardiovascular Medicine 427
- Endocrinology, Diabetes and Metabolism 275
- Molecular Biology 679
- Cellular and Molecular Neuroscience 126
- Physiology 29
Countries citing papers authored by Jan H. Schefe
This map shows the geographic impact of Jan H. Schefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan H. Schefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan H. Schefe more than expected).
Fields of papers citing papers by Jan H. Schefe
This network shows the impact of papers produced by Jan H. Schefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan H. Schefe. The network helps show where Jan H. Schefe may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan H. Schefe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s C T difference” formula Hit paper breakdown → | 2006 | 705 |
| 2 | 2006 | 254 | |
| 3 | 2004 | 99 | |
| 4 | 2008 | 91 | |
| 5 | Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. | 2012 | 89 |
| 6 | 2008 | 81 | |
| 7 | 2008 | 36 | |
| 8 | 2009 | 36 | |
| 9 | 2008 | 28 | |
| 10 | 2009 | 25 | |
| 11 | 2010 | 18 | |
| 12 | 2011 | 16 | |
| 13 | 2010 | 9 | |
| 14 | 2022 | 2 |
About Jan H. Schefe
Jan H. Schefe is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (3 papers), Hormonal Regulation and Hypertension (2 papers), PARP inhibition in cancer therapy (2 papers), Adipose Tissue and Metabolism (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Protein purification and stability (1 paper) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (427 citations), Endocrinology, Diabetes and Metabolism (275 citations), Molecular Biology (679 citations), Cellular and Molecular Neuroscience (126 citations) and Physiology (29 citations). Jan H. Schefe has collaborated with scholars based in Germany, Hungary and Netherlands. Frequent co-authors include Thomas Unger, Heiko Funke‐Kaiser, Kerstin Lehmann, Ivo Buschmann, Mario Menk, Jana Reinemund, Robin M. Hobbs, Karin Effertz, Patricia Ruíz and Pier Paolo Pandolfi. Their work appears in journals such as Journal of Hypertension, Journal of Molecular Medicine, Alcohol, Biochemical Pharmacology and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.